Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma (TRASTS)
NCT02275286Phase 2Recruiting
- Sponsor
- Spanish Group for Research on Sarcoma
- Start
- Nov 2014
- Primary completion
- Jun 2028
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of trabectedin in soft tissue sarcoma (STS), myxoid liposarcoma (MLPS), leiomyosarcoma (LMS), Liposarcoma, retroperitoneal sarcoma (RPS), sponsored by Spanish Group for Research on Sarcoma. Started Nov 2014; status: recruiting.
02
Drugs
trabectedin
03
Conditions
soft tissue sarcoma (STS)myxoid liposarcoma (MLPS)leiomyosarcoma (LMS)Liposarcomaretroperitoneal sarcoma (RPS)
Beyond the preview
Go deeper on NCT02275286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02275286.